Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teppei Yamaguchi

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Elife|July 10, 2014
Core promoter factor TAF9B regulates neuronal gene expressionFrancisco J Herrera, Teppei Yamaguchi, Henk Roelink, et al.
Trends in Cell Biology|May 11, 2012
Transcriptional regulation by coactivators in embryonic stem cellsYick W Fong, Claudia Cattoglio, Teppei Yamaguchi, et al.
Molecular Biology of the Cell|February 3, 2012
The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membraneHidetaka Tanno, Teppei Yamaguchi, Eiji Goto, et al.
Anticancer Research|December 1, 2022
Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLCKazuhiro Shimomura, Teppei Yamaguchi, Yuko Oya, et al.
Case Reports in Oncology|July 12, 2021
Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media InformationTeppei Yamaguchi, Junichi Shimizu, Yuko Oya, et al.
Future Oncology (London, England)|June 7, 2025
J-REGISTER: real-world study of Japanese patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinibTeppei Yamaguchi, Haruko Daga, Hisashi Tanaka, et al.
Case Reports in Oncology|October 27, 2017
Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung CancerTeppei Yamaguchi, Kazuo Sakurai, Makoto Kuroda, et al.
Oncology Letters|July 3, 2018
Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non-small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case reportTeppei Yamaguchi, Yusuke Gotoh, Hidekazu Hattori, et al.
BMC Cancer|July 15, 2024
Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysisTeppei Yamaguchi, Junichi Shimizu, Reiko Matsuzawa, et al.
General and Comparative Endocrinology|September 6, 2011
Circulating salmon 28- and 22-kDa insulin-like growth factor binding proteins (IGFBPs) are co-orthologs of IGFBP-1Munetaka Shimizu, Keisuke Kishimoto, Teppei Yamaguchi, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Elife|July 10, 2014
Core promoter factor TAF9B regulates neuronal gene expressionFrancisco J Herrera, Teppei Yamaguchi, Henk Roelink, et al.
Trends in Cell Biology|May 11, 2012
Transcriptional regulation by coactivators in embryonic stem cellsYick W Fong, Claudia Cattoglio, Teppei Yamaguchi, et al.
Molecular Biology of the Cell|February 3, 2012
The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membraneHidetaka Tanno, Teppei Yamaguchi, Eiji Goto, et al.
Anticancer Research|December 1, 2022
Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLCKazuhiro Shimomura, Teppei Yamaguchi, Yuko Oya, et al.
Case Reports in Oncology|July 12, 2021
Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media InformationTeppei Yamaguchi, Junichi Shimizu, Yuko Oya, et al.
Future Oncology (London, England)|June 7, 2025
J-REGISTER: real-world study of Japanese patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinibTeppei Yamaguchi, Haruko Daga, Hisashi Tanaka, et al.
Case Reports in Oncology|October 27, 2017
Different Response to Nivolumab in a Patient with Synchronous Double Primary Carcinomas of Hypopharyngeal Cancer and Non-Small-Cell Lung CancerTeppei Yamaguchi, Kazuo Sakurai, Makoto Kuroda, et al.
Oncology Letters|July 3, 2018
Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non-small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case reportTeppei Yamaguchi, Yusuke Gotoh, Hidekazu Hattori, et al.
BMC Cancer|July 15, 2024
Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysisTeppei Yamaguchi, Junichi Shimizu, Reiko Matsuzawa, et al.
General and Comparative Endocrinology|September 6, 2011
Circulating salmon 28- and 22-kDa insulin-like growth factor binding proteins (IGFBPs) are co-orthologs of IGFBP-1Munetaka Shimizu, Keisuke Kishimoto, Teppei Yamaguchi, et al.
Pageof 6